Diffuse interstitial lung diseases associated with smoking
DOI:
https://doi.org/10.53732/rccsalud/2023.e5209Keywords:
smoking, emphysema, interstitial lung diseases, Langerhans cell histiocytosisAbstract
Questioning about smoking habits should never be ignored, since the range of inherent diagnostic possibilities is wide. It is a fundamental clinical step facing individuals who consult for symptoms and/or casual radiological findings. We present three clinical cases: the combined syndrome of pulmonary fibrosis and emphysema, desquamative interstitial pneumonitis, and Langerhans cell histiocytosis, as part of the range of tobacco-associated diffuse interstitial lung diseases (EPIDAT), where high-resolution chest tomography has a prominent role.
References
Washko GR, Hunninghake GM, Fernandez IE, Okajima Y, Yamashiro T, Ross JC, et al. Lung volumes andemphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364(10):897–906. https://pubmed.ncbi.nlm.nih.gov/21388308/
Hatabu H, Hunninghake G, Richeldi L, Brown KK, Wells AU, Remy-Jardin M, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med 2020;8(7):726-737. https://doi.org/10.1016/S2213-2600(20)30168-5
Putman RK, Gudmundsson G, Axelsson GT, Hida T, Osamu Honda O, Araki T, et al. Imaging patterns are associatedwith interstitial lung abnormality progression and mortality. Am J Respir Crit Care Med 2019;200(2):175–183. https://pubmed.ncbi.nlm.nih.gov/30673508/
Otani H, Tanaka T, Murata K, Junya Fukuoka 2, Norihisa Nitta 1, Yukihiro Nagatani Y, Sonoda A, et al. Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens. Int J Chron Obstruct Pulmon Dis. 2016; 4;11:1521-32. https://pubmed.ncbi.nlm.nih.gov/27445472/
Katzenstein A-LA. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol 2013;66(10):882–887. https://doi.org/10.1136/jclinpath-2012-201338
Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008;53(6):707–14. https://doi.org/10.1111/j.1365-2559.2008.03183.x
Margaritopoulos GA, Harari S, Caminati A, Antoniou KM. Smoking-related idiopathic interstitial pneumonia: a review. Respirology. 2016;21(1),57–64. https://doi.org/10.1111/resp.12576
Dawod YT, Cook NE, Graham W, Madhani-Lovely F, Thao Ch. Smoking associated interstitial lung disease:update and review. Expert Rev Respir Med. 2020;14(8):825-834. https://pubmed.ncbi.nlm.nih.gov/32379511/
Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. 7, Pulmonary Diseases. https://www.ncbi.nlm.nih.gov/books/NBK53021/
Sangani R, Deepak V, Ghio A, Forte MJ, Zulfikar R, Patel Z, et al. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection. BMC Pulm Med. 2022;22(1):172. https://doi.org/10.1186/s12890-022-01961-9
Hata A, Schiebler M, Lynch D, Hatabu H. Interstitial Lung Abnormalities: State of the Art. Radiology. 2021; 301(1):19–34. https://pubmed.ncbi.nlm.nih.gov/34374589/
Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, et al. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. Am J RespirCrit Care Med 2022;206(4):e7–e41. https://pubmed.ncbi.nlm.nih.gov/35969190/
Ciftci F, Gulpınar B, Atasoy C, Oya Kayacan, Sevgi Saryal. Combined pulmonary fibrosis and emphysema: how does cohabitation affect respiratory functions? Adv Med Sci. 2019;64(2):285–291. https://doi.org/10.1016/j.advms.2019.03.005
Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, Cordier JF. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Resp J. 2010;35(1):105-111; https://doi.org/10.1183/09031936.00038709
Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, Revel D, Valeyre D, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011 Jan;63(1):295-304. https://doi.org/10.1002/art.30077
Godbert B, Wissler MP, Vignaud JM. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. Eur Respir Rev. 2013;22(128):117-23. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487388/
Hellemons ME, Moor CC, von der Thüsen J, y cols. Desquamative interstitial pneumonia: a systematic review of its features and outcomes. Eur Respir Rev 2020; 29: 190181. https://doi.org/10.1183/16000617.0181-2019
Torre O, Elia D, Caminati A, Harari S. New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017; 26(145):170042. https://pubmed.ncbi.nlm.nih.gov/28954765/
Castoldi MC, Verrioli A, De Juli E, Vanzulli A. Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging. 2014;5(4):483-92. https://doi.org/10.1007/s13244-014-0338-0
Vasallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax. 2017; 72(10):937–945. https://pubmed.ncbi.nlm.nih.gov/28689173/
Cong CV, Ly TT, Duc NM. Multisystem Langerhans cell histiocytosis: Literature review and case report. Radiol Case Rep. 2022: 2;17(5):1407-1412. https://doi.org/10.1016/j.radcr.2022.02.024
Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017; 26:170070. https://doi.org/10.1183/16000617.0070-2017
Bardach A, Cañete F, Sequera VG, Palacios A, Alcaraz A, Rodríguez B, et al. Carga de enfermedad atribuible al uso del tabaco en Paraguay y potencial impacto sanitario y económico del aumento del precio a través de impuestos. Rev Peru Med Exp Salud Pública. 2018;35(4):599-609. https://doi.org/10.17843/rpmesp.2018.354.3708
Dai X, Gil GF, Reitsma MB, Noah S. Ahmad, Jason A, et al. Anderson, Catherine Bisignano. Health effects associated with smoking: a Burden of Proof study. Nat Med. 2022;28(10):2045-2055. https://doi.org/10.1038/s41591-022-01978-x
.png)
All the contents of this journal are licensed under a 